If you're a doctor or midwife working in maternity services or feto-maternal medicine, you won't want to miss our East Prenatal Genomic Forum this month: 📅 Monday 16 September 🕐 1pm - 2.30pm MS Teams The topic for this session is 'Prenatal testing in the Genomic Medicine Service' and will cover: - Introduction to prenatal genetic testing - Variants of uncertain significance in prenatal testing - Consolidation of aneuploidy testing within the East GLH - Best practice when ordering prenatal genetic testing Register your free place here: https://lnkd.in/eQm9c7EP This is our third Prenatal Genomics Forum, which aims to bring together the MDT team in prenatal services - across the East Midlands and East of England - to discuss genomics in practice. It will be hosted by the East Genomics Laboratory Hub.
East Genomics
Hospitals and Health Care
The powerhouse of genomic testing for East of England and East Midlands (incorporating East GLH and East GMSA)
About us
East Genomics is the powerhouse for genomic testing across the East of England and East Midlands. It incorporates: - East Genomic Laboratory Hub - which provides and coordinates genomic testing for the region - East Genomic Medicine Service Alliance - which brings together the vital multi-disciplinary clinical leadership and other operational and digital functions necessary to embed genomic medicine into mainstream clinical care. We will ensure all eligible patients across the East Midlands and East of England can access and benefit from appropriate genomic tests when required, ensuring high-quality and personalised treatment.
- Website
-
http://www.eastgenomics.nhs.uk
External link for East Genomics
- Industry
- Hospitals and Health Care
- Company size
- 201-500 employees
- Headquarters
- Cambridge
- Type
- Partnership
- Specialties
- Genomics, Cancer, Rare Disease, Haematological Malignancy, Nursing, Healthcare Professionals, Education, Training, and Oncology
Locations
-
Primary
Cambridge, GB
-
Leicester, GB
-
Nottingham, GB
-
Norfolk and Norwich, GB
Employees at East Genomics
-
Christopher Trethewey, Ph.D.
Scientific Associate - University of Cambridge. Molecular biologist / Bioinformatician / Haematological malignancies.
-
Brent O'Carrigan
Consultant Medical Oncologist at Cambridge University Hospitals NHS Foundation Trust
-
Emma-Louise Gee
Technical Program Manager at East Genomics
-
Aris Saoulidis
Pharmacogenomics | Haematology | Clinical Pharmacist
Updates
-
Blog from Genomics Education Programme which looks at the recent NICE recommendations around #genomic testing and #clopidogrel, depending on the presence of a genomic variant. #stroke #patients #healthcare
In this week's blog, we look at recent NICE recommendations around genomic testing and #clopidogrel, an antiplatelet drug that can help – or harm – those at risk of stroke, depending on the presence of a genomic variant:
-
What do I need to know about genomics? If you're a nurse, midwife, health visitor or you work in pharmacy and you've ever asked yourself that question, our new postcards might just have some answers, as well as lots of links off to further information, training and resources. Find them, and other leaflets, hand outs, posters and resources, on our website: https://lnkd.in/eQj97hvX
-
-
East Genomics reposted this
Have you seen our resources all about #genomics in your specialty? Here, we speak to Dr Kevin Monahan about the significance of genomics in the practice of #gastroenterology: https://buff.ly/3XcLQj6
-
-
We have lots of great roles within our East Genomic Laboratory Hub sites across Cambridge, Nottingham, Leicester and Norwich. Lead Consultant Clinical Scientist (Genomics) Nottingham University Hospitals NHS Trusts Band 8d / Permanent Closing date: 29 September 2024 https://lnkd.in/eirhCW_j Principal Clinical Scientist Cambridge University Hospitals Band 8a / Permanent Closing date: 25 August 2024 https://lnkd.in/eJWUykRJ Healthcare Scientist (Two roles) Cambridge University Hospitals Band 7 Closing date: 25 August 2024 Permanent: https://lnkd.in/euMEQ2sk 12 months Secondment/Fixed Term (Maternity Cover): https://lnkd.in/ePYsJWX8 Healthcare Science Practitioner Cambridge University Hospitals Band 4 / Permanent: Closing date: 1 September 2024 https://lnkd.in/ehWUJRm2
-
-
We're looking for a Research Coordinator to join us, initially for a fixed term period up until March 2026, but with scope to extend beyond that. The overarching purpose of the job is to provide the coordination of research and innovation projects across a complex footprint, involving a range of NHS providers, academic and industry partners and other stakeholders. You can find out more about the role and apply here: https://lnkd.in/eP7wJhtz The application deadline is 1 September at 23:59.
-
-
Get the latest on the #Pharmacogenomics Network of #Excellence at the NHS North West Genomic Medicine Service Alliance event for healthcare professionals on 17 Oct 2024. Hear about progress to date plus future plans. Be part of the future of healthcare...
Get the latest updates on the #Pharmacogenomics Network of #Excellence at our event for #healthcare professionals on 17 Oct 2024. Hear about progress to date and future plans. Be part of the future of healthcare. Info and registration at https://bit.ly/PGxOct24 #PGx #genomics #PatientCare #HealthCare
-
Around 100,000 people in the UK each year will have a stroke – a serious life-threatening condition that happens when the blood supply to part of the brain is cut off by a blood clot. Clopidogrel prevents platelets (a type of blood cell) from sticking together and forming a dangerous blood clot. However, around 29 per cent of all patients in the UK (and up to 60 per cent in different ethnic groups) have a change in the CYP2C19 gene which reduces clopidogrel’s effectiveness. Individuals carrying changes in the CYP2C19 gene are also twice as likely to have further strokes when treated with clopidogrel. If these genetic changes can be detected before treatment, then doctors can use an alternative, more effective medicine. To read the full article please visit:
🗞️ Manchester leads implementation of lifesaving genetic bedside stroke test. An innovative bedside genetic test developed by researchers at Manchester University NHS Foundation Trust and The University of Manchester, in collaboration with genedrive, being implemented in Manchester, could dramatically improve outcomes for thousands of people in the UK affected by stroke each year. Approximately 100,000 people in the UK each year will have a stroke – a serious life-threatening condition that happens when the blood supply to part of the brain is cut off by a blood clot. Using a simple cheek swab, genetic the test can tell healthcare professionals in approximately one hour if stroke patients will be more likely to benefit from clopidogrel, the current first-line treatment to prevent recurrence. 🧬🧪 Incredible research led by Professor William Newman and Dr John H McDermott👏. 👇 https://lnkd.in/e8rW5UZv
-
-
Our our July newsletter is out now and available to view on our website: https://lnkd.in/eueAgcXQ With updates, news, events and training from Genomics Education Programme, Cambridge University Hospitals NHS Foundation Trust, NEYGenomics, Jeans for Genes UK, SWAN UK, Unique, Nursing Live UK, University of Cambridge Institute of Continuing Education, University of East Anglia and more. Sign up to receive them here: https://lnkd.in/eB6YSijG
-
East Genomics reposted this
Working with partners and patient groups, we have developed the Rare Disease Education Hub, a resource for healthcare professionals with an interest in learning more about #RareDiseases, their diagnosis and treatment: https://buff.ly/48Y7Vo3
-